ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$88.92
*  
0.93
1.06%
Get ALNY Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech: On The Way To Meeting Highly Ambitious Expectations
9/10/2012 11:41:00 AM - Seeking Alpha


Alnylam Presents Data on ALN-RSV01 - Analyst Blog
9/6/2012 7:17:01 PM - Zacks.com


Alnylam & Monsanto Collaborate - Analyst Blog
8/29/2012 5:33:54 PM - Zacks.com


Alnylam/Isis's Regulus to Go Public - Analyst Blog
8/22/2012 7:18:01 PM - Zacks.com


Biogen Inks Deal with Regulus - Analyst Blog
8/16/2012 6:22:50 PM - Zacks.com


Alnylam Pharma Revs In-Line - Analyst Blog
8/7/2012 3:08:01 PM - Zacks.com


Alnylam Earns Milestone Payment - Analyst Blog
8/6/2012 4:15:01 PM - Zacks.com


Zacks #1 Rank Additions for Monday - Tale of the Tape
8/6/2012 9:14:01 AM - Zacks.com


Zacks #1 Rank Additions for Thursday - Tale of the Tape
8/2/2012 9:14:01 AM - Zacks.com


Zacks #1 Rank Additions for Friday - Tale of the Tape
7/27/2012 9:14:01 AM - Zacks.com


Zacks #1 Rank Additions for Tuesday - Tale of the Tape
7/24/2012 9:11:09 AM - Zacks.com


Positive Data on Alnylam Candidate - Analyst Blog
7/23/2012 5:09:37 PM - Zacks.com


Zacks #1 Rank Additions for Friday - Tale of the Tape
7/20/2012 9:10:23 AM - Zacks.com


Company News for July 17, 2012 - Corporate Summary
7/17/2012 9:47:26 AM - Zacks.com


Alnylam Inks Oncology Deal - Analyst Blog
7/13/2012 4:47:38 PM - Zacks.com


Orphan Status for Alnylam Drug - Analyst Blog
6/21/2012 10:45:01 AM - Zacks.com


How the Short Ratio Can Lead to Big Gains - Screen of the Week
6/12/2012 1:00:01 AM - Zacks.com


Alnylam Narrows Loss - Analyst Blog
5/4/2012 1:38:01 PM - Zacks.com


The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases
3/28/2012 9:24:38 AM - Zacks.com


Encouraging Data on Amgen Candidate - Analyst Blog
3/27/2012 12:22:16 PM - Zacks.com


What Alnylam Doesn't Want You To Know
3/16/2012 9:54:00 AM - Seeking Alpha


Good News For Alnylam: PBL Making Baulcombe Patent Widely Available
3/11/2012 11:18:00 AM - Seeking Alpha


Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
3/8/2012 6:24:00 PM - Seeking Alpha


Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts
3/7/2012 8:13:00 AM - Seeking Alpha


Noteworthy Insider Buys And Sells In Healthcare On Wednesday To Friday
2/26/2012 4:10:00 AM - Seeking Alpha